JP6226888B2 - ポリマーの測定の解析 - Google Patents
ポリマーの測定の解析 Download PDFInfo
- Publication number
- JP6226888B2 JP6226888B2 JP2014557122A JP2014557122A JP6226888B2 JP 6226888 B2 JP6226888 B2 JP 6226888B2 JP 2014557122 A JP2014557122 A JP 2014557122A JP 2014557122 A JP2014557122 A JP 2014557122A JP 6226888 B2 JP6226888 B2 JP 6226888B2
- Authority
- JP
- Japan
- Prior art keywords
- feature vector
- polymer
- measurements
- derived
- similarity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000005259 measurement Methods 0.000 title claims description 218
- 229920000642 polymer Polymers 0.000 title claims description 186
- 238000004458 analytical method Methods 0.000 title claims description 23
- 239000013598 vector Substances 0.000 claims description 289
- 238000000034 method Methods 0.000 claims description 196
- 239000011148 porous material Substances 0.000 claims description 159
- 102000040430 polynucleotide Human genes 0.000 claims description 90
- 108091033319 polynucleotide Proteins 0.000 claims description 90
- 239000002157 polynucleotide Substances 0.000 claims description 90
- 125000003729 nucleotide group Chemical group 0.000 claims description 60
- 239000002773 nucleotide Substances 0.000 claims description 59
- 239000012634 fragment Substances 0.000 claims description 32
- 238000003860 storage Methods 0.000 claims description 31
- 102000035160 transmembrane proteins Human genes 0.000 claims description 17
- 108091005703 transmembrane proteins Proteins 0.000 claims description 17
- 108090000623 proteins and genes Proteins 0.000 claims description 14
- 239000007787 solid Substances 0.000 claims description 14
- 102000004169 proteins and genes Human genes 0.000 claims description 11
- 238000009826 distribution Methods 0.000 claims description 9
- 229920000891 common polymer Polymers 0.000 claims description 7
- 238000004590 computer program Methods 0.000 claims description 4
- 230000003287 optical effect Effects 0.000 claims description 4
- 230000002123 temporal effect Effects 0.000 claims description 3
- 239000011810 insulating material Substances 0.000 claims description 2
- 238000011524 similarity measure Methods 0.000 claims description 2
- 230000002730 additional effect Effects 0.000 claims 1
- 102000053602 DNA Human genes 0.000 description 62
- 108020004414 DNA Proteins 0.000 description 62
- 102000004190 Enzymes Human genes 0.000 description 49
- 108090000790 Enzymes Proteins 0.000 description 49
- 235000001014 amino acid Nutrition 0.000 description 47
- 150000001413 amino acids Chemical class 0.000 description 41
- 239000000523 sample Substances 0.000 description 38
- 238000004422 calculation algorithm Methods 0.000 description 32
- 239000012528 membrane Substances 0.000 description 29
- 108060004795 Methyltransferase Proteins 0.000 description 25
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 23
- 239000000178 monomer Substances 0.000 description 23
- 125000003275 alpha amino acid group Chemical group 0.000 description 22
- 230000033001 locomotion Effects 0.000 description 20
- 230000004048 modification Effects 0.000 description 20
- 238000012986 modification Methods 0.000 description 20
- 230000032258 transport Effects 0.000 description 20
- 239000000232 Lipid Bilayer Substances 0.000 description 19
- 239000010410 layer Substances 0.000 description 19
- 230000005684 electric field Effects 0.000 description 18
- 102000004196 processed proteins & peptides Human genes 0.000 description 17
- 108090000765 processed proteins & peptides Proteins 0.000 description 17
- 238000013459 approach Methods 0.000 description 16
- 238000002474 experimental method Methods 0.000 description 16
- 230000006870 function Effects 0.000 description 16
- 229920001184 polypeptide Polymers 0.000 description 16
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 15
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 15
- 230000003993 interaction Effects 0.000 description 14
- 150000003839 salts Chemical class 0.000 description 14
- 238000006467 substitution reaction Methods 0.000 description 14
- 108091006146 Channels Proteins 0.000 description 12
- -1 Nucleotide sugars Chemical class 0.000 description 12
- 239000002585 base Substances 0.000 description 12
- 230000027455 binding Effects 0.000 description 12
- GYOZYWVXFNDGLU-XLPZGREQSA-N dTMP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)C1 GYOZYWVXFNDGLU-XLPZGREQSA-N 0.000 description 12
- 230000000694 effects Effects 0.000 description 11
- 230000035772 mutation Effects 0.000 description 11
- 150000007523 nucleic acids Chemical class 0.000 description 11
- 101710092462 Alpha-hemolysin Proteins 0.000 description 10
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 10
- 239000012491 analyte Substances 0.000 description 10
- 102000039446 nucleic acids Human genes 0.000 description 10
- 108020004707 nucleic acids Proteins 0.000 description 10
- 235000018102 proteins Nutrition 0.000 description 10
- 230000015572 biosynthetic process Effects 0.000 description 9
- 201000010099 disease Diseases 0.000 description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- 239000000463 material Substances 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 description 8
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 8
- 108060002716 Exonuclease Proteins 0.000 description 8
- 238000001514 detection method Methods 0.000 description 8
- 102000013165 exonuclease Human genes 0.000 description 8
- 150000002500 ions Chemical class 0.000 description 8
- 239000000872 buffer Substances 0.000 description 7
- 229910052751 metal Inorganic materials 0.000 description 7
- 239000002184 metal Substances 0.000 description 7
- 238000012545 processing Methods 0.000 description 7
- 229920002477 rna polymer Polymers 0.000 description 7
- KHWCHTKSEGGWEX-RRKCRQDMSA-N 2'-deoxyadenosine 5'-monophosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(O)=O)O1 KHWCHTKSEGGWEX-RRKCRQDMSA-N 0.000 description 6
- NCMVOABPESMRCP-SHYZEUOFSA-N 2'-deoxycytosine 5'-monophosphate Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)C1 NCMVOABPESMRCP-SHYZEUOFSA-N 0.000 description 6
- LTFMZDNNPPEQNG-KVQBGUIXSA-N 2'-deoxyguanosine 5'-monophosphate Chemical compound C1=2NC(N)=NC(=O)C=2N=CN1[C@H]1C[C@H](O)[C@@H](COP(O)(O)=O)O1 LTFMZDNNPPEQNG-KVQBGUIXSA-N 0.000 description 6
- 108020004682 Single-Stranded DNA Proteins 0.000 description 6
- DJJCXFVJDGTHFX-UHFFFAOYSA-N Uridinemonophosphate Natural products OC1C(O)C(COP(O)(O)=O)OC1N1C(=O)NC(=O)C=C1 DJJCXFVJDGTHFX-UHFFFAOYSA-N 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 238000013461 design Methods 0.000 description 6
- 230000001605 fetal effect Effects 0.000 description 6
- 239000012530 fluid Substances 0.000 description 6
- RQFCJASXJCIDSX-UUOKFMHZSA-N guanosine 5'-monophosphate Chemical compound C1=2NC(N)=NC(=O)C=2N=CN1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O RQFCJASXJCIDSX-UUOKFMHZSA-N 0.000 description 6
- 235000013928 guanylic acid Nutrition 0.000 description 6
- 238000000338 in vitro Methods 0.000 description 6
- 230000000670 limiting effect Effects 0.000 description 6
- 230000011987 methylation Effects 0.000 description 6
- 238000007069 methylation reaction Methods 0.000 description 6
- 230000002829 reductive effect Effects 0.000 description 6
- 238000012163 sequencing technique Methods 0.000 description 6
- 238000012549 training Methods 0.000 description 6
- DJJCXFVJDGTHFX-XVFCMESISA-N uridine 5'-monophosphate Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(O)=O)O[C@H]1N1C(=O)NC(=O)C=C1 DJJCXFVJDGTHFX-XVFCMESISA-N 0.000 description 6
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical group [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 5
- 238000007792 addition Methods 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 235000018417 cysteine Nutrition 0.000 description 5
- IERHLVCPSMICTF-XVFCMESISA-N cytidine 5'-monophosphate Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(O)=O)O1 IERHLVCPSMICTF-XVFCMESISA-N 0.000 description 5
- IERHLVCPSMICTF-UHFFFAOYSA-N cytidine monophosphate Natural products O=C1N=C(N)C=CN1C1C(O)C(O)C(COP(O)(O)=O)O1 IERHLVCPSMICTF-UHFFFAOYSA-N 0.000 description 5
- FTDHDKPUHBLBTL-SHYZEUOFSA-N dCDP Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 FTDHDKPUHBLBTL-SHYZEUOFSA-N 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 238000011002 quantification Methods 0.000 description 5
- 239000011780 sodium chloride Substances 0.000 description 5
- 238000003786 synthesis reaction Methods 0.000 description 5
- 230000007704 transition Effects 0.000 description 5
- XTWYTFMLZFPYCI-KQYNXXCUSA-N 5'-adenylphosphoric acid Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O XTWYTFMLZFPYCI-KQYNXXCUSA-N 0.000 description 4
- XTWYTFMLZFPYCI-UHFFFAOYSA-N Adenosine diphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(O)=O)C(O)C1O XTWYTFMLZFPYCI-UHFFFAOYSA-N 0.000 description 4
- ZWIADYZPOWUWEW-XVFCMESISA-N CDP Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(O)=O)O1 ZWIADYZPOWUWEW-XVFCMESISA-N 0.000 description 4
- 102000014914 Carrier Proteins Human genes 0.000 description 4
- IVOMOUWHDPKRLL-KQYNXXCUSA-N Cyclic adenosine monophosphate Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-KQYNXXCUSA-N 0.000 description 4
- PCDQPRRSZKQHHS-CCXZUQQUSA-N Cytarabine Triphosphate Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 PCDQPRRSZKQHHS-CCXZUQQUSA-N 0.000 description 4
- AHCYMLUZIRLXAA-SHYZEUOFSA-N Deoxyuridine 5'-triphosphate Chemical compound O1[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C[C@@H]1N1C(=O)NC(=O)C=C1 AHCYMLUZIRLXAA-SHYZEUOFSA-N 0.000 description 4
- QGWNDRXFNXRZMB-UUOKFMHZSA-N GDP Chemical compound C1=2NC(N)=NC(=O)C=2N=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O QGWNDRXFNXRZMB-UUOKFMHZSA-N 0.000 description 4
- XKMLYUALXHKNFT-UUOKFMHZSA-N Guanosine-5'-triphosphate Chemical compound C1=2NC(N)=NC(=O)C=2N=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O XKMLYUALXHKNFT-UUOKFMHZSA-N 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 108091028043 Nucleic acid sequence Proteins 0.000 description 4
- RZCIEJXAILMSQK-JXOAFFINSA-N TTP Chemical compound O=C1NC(=O)C(C)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 RZCIEJXAILMSQK-JXOAFFINSA-N 0.000 description 4
- XCCTYIAWTASOJW-XVFCMESISA-N Uridine-5'-Diphosphate Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(=O)OP(O)(O)=O)O[C@H]1N1C(=O)NC(=O)C=C1 XCCTYIAWTASOJW-XVFCMESISA-N 0.000 description 4
- BZDVTEPMYMHZCR-JGVFFNPUSA-N [(2s,5r)-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methyl phosphono hydrogen phosphate Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(O)=O)CC1 BZDVTEPMYMHZCR-JGVFFNPUSA-N 0.000 description 4
- UDMBCSSLTHHNCD-KQYNXXCUSA-N adenosine 5'-monophosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O UDMBCSSLTHHNCD-KQYNXXCUSA-N 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 239000012472 biological sample Substances 0.000 description 4
- 239000007853 buffer solution Substances 0.000 description 4
- 150000001768 cations Chemical class 0.000 description 4
- ZOOGRGPOEVQQDX-KHLHZJAASA-N cyclic guanosine monophosphate Chemical compound C([C@H]1O2)O[P@](O)(=O)O[C@@H]1[C@H](O)[C@H]2N1C(N=C(NC2=O)N)=C2N=C1 ZOOGRGPOEVQQDX-KHLHZJAASA-N 0.000 description 4
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 4
- DAEAPNUQQAICNR-RRKCRQDMSA-K dADP(3-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP([O-])(=O)OP([O-])([O-])=O)O1 DAEAPNUQQAICNR-RRKCRQDMSA-K 0.000 description 4
- SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 4
- RGWHQCVHVJXOKC-SHYZEUOFSA-N dCTP Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OP(O)(O)=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-N 0.000 description 4
- CIKGWCTVFSRMJU-KVQBGUIXSA-N dGDP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(O)=O)O1 CIKGWCTVFSRMJU-KVQBGUIXSA-N 0.000 description 4
- HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 description 4
- UJLXYODCHAELLY-XLPZGREQSA-N dTDP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 UJLXYODCHAELLY-XLPZGREQSA-N 0.000 description 4
- NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 description 4
- QHWZTVCCBMIIKE-SHYZEUOFSA-N dUDP Chemical compound O1[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)C[C@@H]1N1C(=O)NC(=O)C=C1 QHWZTVCCBMIIKE-SHYZEUOFSA-N 0.000 description 4
- JSRLJPSBLDHEIO-SHYZEUOFSA-N dUMP Chemical compound O1[C@H](COP(O)(O)=O)[C@@H](O)C[C@@H]1N1C(=O)NC(=O)C=C1 JSRLJPSBLDHEIO-SHYZEUOFSA-N 0.000 description 4
- 238000003745 diagnosis Methods 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 230000004927 fusion Effects 0.000 description 4
- 230000014509 gene expression Effects 0.000 description 4
- QGWNDRXFNXRZMB-UHFFFAOYSA-N guanidine diphosphate Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1OC(COP(O)(=O)OP(O)(O)=O)C(O)C1O QGWNDRXFNXRZMB-UHFFFAOYSA-N 0.000 description 4
- 239000011159 matrix material Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 235000000346 sugar Nutrition 0.000 description 4
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- 108010013381 Porins Proteins 0.000 description 3
- 102000017033 Porins Human genes 0.000 description 3
- 230000002776 aggregation Effects 0.000 description 3
- 238000004220 aggregation Methods 0.000 description 3
- 239000000427 antigen Substances 0.000 description 3
- 108091007433 antigens Proteins 0.000 description 3
- 102000036639 antigens Human genes 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 238000003491 array Methods 0.000 description 3
- 239000000090 biomarker Substances 0.000 description 3
- 210000004899 c-terminal region Anatomy 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 210000000349 chromosome Anatomy 0.000 description 3
- 239000002131 composite material Substances 0.000 description 3
- 238000012217 deletion Methods 0.000 description 3
- 230000037430 deletion Effects 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 230000002255 enzymatic effect Effects 0.000 description 3
- 210000003743 erythrocyte Anatomy 0.000 description 3
- 210000003754 fetus Anatomy 0.000 description 3
- 230000002068 genetic effect Effects 0.000 description 3
- 238000010801 machine learning Methods 0.000 description 3
- 230000008774 maternal effect Effects 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 238000010561 standard procedure Methods 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- SXUXMRMBWZCMEN-UHFFFAOYSA-N 2'-O-methyl uridine Natural products COC1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 SXUXMRMBWZCMEN-UHFFFAOYSA-N 0.000 description 2
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical group OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 2
- 208000035657 Abasia Diseases 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 108010078791 Carrier Proteins Proteins 0.000 description 2
- UDMBCSSLTHHNCD-UHFFFAOYSA-N Coenzym Q(11) Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(O)=O)C(O)C1O UDMBCSSLTHHNCD-UHFFFAOYSA-N 0.000 description 2
- 150000008574 D-amino acids Chemical class 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 108091093094 Glycol nucleic acid Proteins 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 101710203389 Outer membrane porin F Proteins 0.000 description 2
- 108091093037 Peptide nucleic acid Proteins 0.000 description 2
- 108091046915 Threose nucleic acid Proteins 0.000 description 2
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 2
- PGAVKCOVUIYSFO-UHFFFAOYSA-N [[5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate Chemical compound OC1C(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)OC1N1C(=O)NC(=O)C=C1 PGAVKCOVUIYSFO-UHFFFAOYSA-N 0.000 description 2
- LNQVTSROQXJCDD-UHFFFAOYSA-N adenosine monophosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(CO)C(OP(O)(O)=O)C1O LNQVTSROQXJCDD-UHFFFAOYSA-N 0.000 description 2
- 125000000539 amino acid group Chemical group 0.000 description 2
- 238000004082 amperometric method Methods 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 108091008324 binding proteins Proteins 0.000 description 2
- 239000006172 buffering agent Substances 0.000 description 2
- AIYUHDOJVYHVIT-UHFFFAOYSA-M caesium chloride Chemical compound [Cl-].[Cs+] AIYUHDOJVYHVIT-UHFFFAOYSA-M 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- 239000002800 charge carrier Substances 0.000 description 2
- 150000003841 chloride salts Chemical class 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- FPUGCISOLXNPPC-IOSLPCCCSA-N cordysinin B Chemical compound CO[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(N)=C2N=C1 FPUGCISOLXNPPC-IOSLPCCCSA-N 0.000 description 2
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 2
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 2
- 238000003066 decision tree Methods 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 238000009795 derivation Methods 0.000 description 2
- 239000003792 electrolyte Substances 0.000 description 2
- 238000002001 electrophysiology Methods 0.000 description 2
- 230000007831 electrophysiology Effects 0.000 description 2
- 238000013467 fragmentation Methods 0.000 description 2
- 238000006062 fragmentation reaction Methods 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 229910021389 graphene Inorganic materials 0.000 description 2
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
- 229920001519 homopolymer Polymers 0.000 description 2
- 238000009396 hybridization Methods 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 239000002502 liposome Substances 0.000 description 2
- 235000018977 lysine Nutrition 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 150000004712 monophosphates Chemical class 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 239000011368 organic material Substances 0.000 description 2
- 230000036961 partial effect Effects 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 239000001103 potassium chloride Substances 0.000 description 2
- 235000011164 potassium chloride Nutrition 0.000 description 2
- 239000000276 potassium ferrocyanide Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000006722 reduction reaction Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 102200160490 rs1800299 Human genes 0.000 description 2
- 102200037599 rs749038326 Human genes 0.000 description 2
- 102220143003 rs753997345 Human genes 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 238000002864 sequence alignment Methods 0.000 description 2
- 238000004088 simulation Methods 0.000 description 2
- 229920001059 synthetic polymer Polymers 0.000 description 2
- 230000009897 systematic effect Effects 0.000 description 2
- XOGGUFAVLNCTRS-UHFFFAOYSA-N tetrapotassium;iron(2+);hexacyanide Chemical compound [K+].[K+].[K+].[K+].[Fe+2].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-] XOGGUFAVLNCTRS-UHFFFAOYSA-N 0.000 description 2
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 108700012359 toxins Proteins 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- MQAYPFVXSPHGJM-UHFFFAOYSA-M trimethyl(phenyl)azanium;chloride Chemical compound [Cl-].C[N+](C)(C)C1=CC=CC=C1 MQAYPFVXSPHGJM-UHFFFAOYSA-M 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- MUSPKJVFRAYWAR-XVFCMESISA-N 1-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)thiolan-2-yl]pyrimidine-2,4-dione Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)S[C@H]1N1C(=O)NC(=O)C=C1 MUSPKJVFRAYWAR-XVFCMESISA-N 0.000 description 1
- QPHRQMAYYMYWFW-FJGDRVTGSA-N 1-[(2r,3s,4r,5r)-3-fluoro-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione Chemical compound O[C@]1(F)[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 QPHRQMAYYMYWFW-FJGDRVTGSA-N 0.000 description 1
- HRSBDXXXHGAUJF-QJPTWQEYSA-N 1-[(2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-pent-1-ynylpyrimidine-2,4-dione Chemical compound O=C1NC(=O)C(C#CCCC)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 HRSBDXXXHGAUJF-QJPTWQEYSA-N 0.000 description 1
- BMQZYMYBQZGEEY-UHFFFAOYSA-M 1-ethyl-3-methylimidazolium chloride Chemical compound [Cl-].CCN1C=C[N+](C)=C1 BMQZYMYBQZGEEY-UHFFFAOYSA-M 0.000 description 1
- PXFBZOLANLWPMH-UHFFFAOYSA-N 16-Epiaffinine Natural products C1C(C2=CC=CC=C2N2)=C2C(=O)CC2C(=CC)CN(C)C1C2CO PXFBZOLANLWPMH-UHFFFAOYSA-N 0.000 description 1
- FPUGCISOLXNPPC-UHFFFAOYSA-N 2'-O-Methyladenosine Natural products COC1C(O)C(CO)OC1N1C2=NC=NC(N)=C2N=C1 FPUGCISOLXNPPC-UHFFFAOYSA-N 0.000 description 1
- RFCQJGFZUQFYRF-UHFFFAOYSA-N 2'-O-Methylcytidine Natural products COC1C(O)C(CO)OC1N1C(=O)N=C(N)C=C1 RFCQJGFZUQFYRF-UHFFFAOYSA-N 0.000 description 1
- OVYNGSFVYRPRCG-UHFFFAOYSA-N 2'-O-Methylguanosine Natural products COC1C(O)C(CO)OC1N1C(NC(N)=NC2=O)=C2N=C1 OVYNGSFVYRPRCG-UHFFFAOYSA-N 0.000 description 1
- RFCQJGFZUQFYRF-ZOQUXTDFSA-N 2'-O-methylcytidine Chemical compound CO[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)N=C(N)C=C1 RFCQJGFZUQFYRF-ZOQUXTDFSA-N 0.000 description 1
- OVYNGSFVYRPRCG-KQYNXXCUSA-N 2'-O-methylguanosine Chemical compound CO[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(N=C(N)NC2=O)=C2N=C1 OVYNGSFVYRPRCG-KQYNXXCUSA-N 0.000 description 1
- SXUXMRMBWZCMEN-ZOQUXTDFSA-N 2'-O-methyluridine Chemical compound CO[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 SXUXMRMBWZCMEN-ZOQUXTDFSA-N 0.000 description 1
- DLHNIFPAUZVLLA-XLPZGREQSA-N 2'-deoxy-5-hydroxymethyl-CTP Chemical compound C1=C(CO)C(N)=NC(=O)N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 DLHNIFPAUZVLLA-XLPZGREQSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical group Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- ASJSAQIRZKANQN-CRCLSJGQSA-N 2-deoxy-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)CC=O ASJSAQIRZKANQN-CRCLSJGQSA-N 0.000 description 1
- LMZHZBVAKAMCEG-FJGDRVTGSA-N 4-amino-1-[(2r,3r,4r,5r)-3-amino-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@@](O)(N)[C@H](O)[C@@H](CO)O1 LMZHZBVAKAMCEG-FJGDRVTGSA-N 0.000 description 1
- GAKJJSAXUFZQTL-XVFCMESISA-N 4-amino-1-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)thiolan-2-yl]pyrimidin-2-one Chemical class O=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)S1 GAKJJSAXUFZQTL-XVFCMESISA-N 0.000 description 1
- PJWBTAIPBFWVHX-FJGDRVTGSA-N 4-amino-1-[(2r,3s,4r,5r)-3-fluoro-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@](F)(O)[C@H](O)[C@@H](CO)O1 PJWBTAIPBFWVHX-FJGDRVTGSA-N 0.000 description 1
- YAWQLNSJZSCVAG-TURQNECASA-N 5-(3-aminopropyl)-1-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione Chemical compound O=C1NC(=O)C(CCCN)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 YAWQLNSJZSCVAG-TURQNECASA-N 0.000 description 1
- BTIWPBKNTZFNRI-XLPZGREQSA-N 5-hydroxymethyldeoxycytidylic acid Chemical compound C1=C(CO)C(N)=NC(=O)N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)C1 BTIWPBKNTZFNRI-XLPZGREQSA-N 0.000 description 1
- NGYHUCPPLJOZIX-XLPZGREQSA-N 5-methyl-dCTP Chemical compound O=C1N=C(N)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NGYHUCPPLJOZIX-XLPZGREQSA-N 0.000 description 1
- NJQONZSFUKNYOY-JXOAFFINSA-N 5-methylcytidine 5'-monophosphate Chemical compound O=C1N=C(N)C(C)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(O)=O)O1 NJQONZSFUKNYOY-JXOAFFINSA-N 0.000 description 1
- SHFOWZBOBJJZAP-XLPZGREQSA-N 5-methyldeoxycytidine 5'-(trihydrogen diphosphate) Chemical compound O=C1N=C(N)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 SHFOWZBOBJJZAP-XLPZGREQSA-N 0.000 description 1
- 108091006112 ATPases Proteins 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- 102000057290 Adenosine Triphosphatases Human genes 0.000 description 1
- 229910018072 Al 2 O 3 Inorganic materials 0.000 description 1
- 108091023037 Aptamer Proteins 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 235000007319 Avena orientalis Nutrition 0.000 description 1
- 244000075850 Avena orientalis Species 0.000 description 1
- 241000193738 Bacillus anthracis Species 0.000 description 1
- 101100031699 Bacillus subtilis (strain 168) bglP gene Proteins 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 108010071023 Bacterial Outer Membrane Proteins Proteins 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 235000014698 Brassica juncea var multisecta Nutrition 0.000 description 1
- 235000006008 Brassica napus var napus Nutrition 0.000 description 1
- 240000000385 Brassica napus var. napus Species 0.000 description 1
- 235000006618 Brassica rapa subsp oleifera Nutrition 0.000 description 1
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 1
- 102220484866 C-type lectin domain family 4 member A_W21A_mutation Human genes 0.000 description 1
- 102220548139 Calpain-2 catalytic subunit_D22E_mutation Human genes 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
- 230000004568 DNA-binding Effects 0.000 description 1
- 229920004943 Delrin® Polymers 0.000 description 1
- 241000283073 Equus caballus Species 0.000 description 1
- 241000701959 Escherichia virus Lambda Species 0.000 description 1
- 108010007577 Exodeoxyribonuclease I Proteins 0.000 description 1
- 102100029075 Exonuclease 1 Human genes 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 241000219146 Gossypium Species 0.000 description 1
- 239000007995 HEPES buffer Substances 0.000 description 1
- 108010006464 Hemolysin Proteins Proteins 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 150000008575 L-amino acids Chemical class 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 235000014647 Lens culinaris subsp culinaris Nutrition 0.000 description 1
- 244000043158 Lens esculenta Species 0.000 description 1
- 108010014603 Leukocidins Proteins 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 244000070406 Malus silvestris Species 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 108010052285 Membrane Proteins Proteins 0.000 description 1
- 108091092878 Microsatellite Proteins 0.000 description 1
- 108020005196 Mitochondrial DNA Proteins 0.000 description 1
- 240000005561 Musa balbisiana Species 0.000 description 1
- 241000187480 Mycobacterium smegmatis Species 0.000 description 1
- OKIZCWYLBDKLSU-UHFFFAOYSA-M N,N,N-Trimethylmethanaminium chloride Chemical compound [Cl-].C[N+](C)(C)C OKIZCWYLBDKLSU-UHFFFAOYSA-M 0.000 description 1
- 241000588653 Neisseria Species 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 101710116435 Outer membrane protein Proteins 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 208000031481 Pathologic Constriction Diseases 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 108010076504 Protein Sorting Signals Proteins 0.000 description 1
- 108091036333 Rapid DNA Proteins 0.000 description 1
- 102220637688 Ras-related protein Rab-33A_D91G_mutation Human genes 0.000 description 1
- 108091028664 Ribonucleotide Proteins 0.000 description 1
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 108010090804 Streptavidin Proteins 0.000 description 1
- 241000282898 Sus scrofa Species 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- 235000009470 Theobroma cacao Nutrition 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 241000039733 Thermoproteus thermophilus Species 0.000 description 1
- 101710183280 Topoisomerase Proteins 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 108010073429 Type V Secretion Systems Proteins 0.000 description 1
- 101710100170 Unknown protein Proteins 0.000 description 1
- DRTQHJPVMGBUCF-XVFCMESISA-N Uridine Natural products O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-XVFCMESISA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 241000219094 Vitaceae Species 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- DCCXPNUFBSYLHZ-DAGMQNCNSA-N [(2R,3S,4R,5R)-5-(4-amino-5-hydroxy-2-oxopyrimidin-1-yl)-3,4-dihydroxy-5-methyloxolan-2-yl]methyl dihydrogen phosphate Chemical compound P(=O)(O)(O)OC[C@@H]1[C@H]([C@H]([C@@](O1)(N1C(=O)N=C(N)C(=C1)O)C)O)O DCCXPNUFBSYLHZ-DAGMQNCNSA-N 0.000 description 1
- OWNKJJAVEHMKCW-XVFCMESISA-N [(2r,3s,4r,5r)-4-amino-5-(2,4-dioxopyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methyl dihydrogen phosphate Chemical compound N[C@@H]1[C@H](O)[C@@H](COP(O)(O)=O)O[C@H]1N1C(=O)NC(=O)C=C1 OWNKJJAVEHMKCW-XVFCMESISA-N 0.000 description 1
- KHIXTHDBCAQXRC-JXOAFFINSA-N [(2r,3s,4r,5r)-5-(4-amino-5-methyl-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphono hydrogen phosphate Chemical compound O=C1N=C(N)C(C)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(O)=O)O1 KHIXTHDBCAQXRC-JXOAFFINSA-N 0.000 description 1
- JVCCCMWZAFGSPD-JXOAFFINSA-N [(2r,3s,4r,5r)-5-[4-amino-5-(hydroxymethyl)-2-oxopyrimidin-1-yl]-3,4-dihydroxyoxolan-2-yl]methyl phosphono hydrogen phosphate Chemical compound C1=C(CO)C(N)=NC(=O)N1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(O)=O)O1 JVCCCMWZAFGSPD-JXOAFFINSA-N 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- YIJVOACVHQZMKI-JXOAFFINSA-N [[(2r,3s,4r,5r)-5-(4-amino-5-methyl-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate Chemical compound O=C1N=C(N)C(C)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 YIJVOACVHQZMKI-JXOAFFINSA-N 0.000 description 1
- NAOOSVVUTFPWHI-JXOAFFINSA-N [[(2r,3s,4r,5r)-5-[4-amino-5-(hydroxymethyl)-2-oxopyrimidin-1-yl]-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate Chemical compound C1=C(CO)C(N)=NC(=O)N1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 NAOOSVVUTFPWHI-JXOAFFINSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000010933 acylation Effects 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 229910001514 alkali metal chloride Inorganic materials 0.000 description 1
- 239000002776 alpha toxin Substances 0.000 description 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
- 230000009435 amidation Effects 0.000 description 1
- 238000007112 amidation reaction Methods 0.000 description 1
- 210000004381 amniotic fluid Anatomy 0.000 description 1
- 208000036878 aneuploidy Diseases 0.000 description 1
- 231100001075 aneuploidy Toxicity 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 235000021016 apples Nutrition 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 238000013528 artificial neural network Methods 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N aspartic acid group Chemical group N[C@@H](CC(=O)O)C(=O)O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 235000021015 bananas Nutrition 0.000 description 1
- 238000002869 basic local alignment search tool Methods 0.000 description 1
- DRTQHJPVMGBUCF-PSQAKQOGSA-N beta-L-uridine Natural products O[C@H]1[C@@H](O)[C@H](CO)O[C@@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-PSQAKQOGSA-N 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000002790 cross-validation Methods 0.000 description 1
- 229940104302 cytosine Drugs 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000005547 deoxyribonucleotide Substances 0.000 description 1
- 125000002637 deoxyribonucleotide group Chemical group 0.000 description 1
- 239000001177 diphosphate Substances 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 1
- 235000011180 diphosphates Nutrition 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000009088 enzymatic function Effects 0.000 description 1
- 230000009144 enzymatic modification Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 108010052305 exodeoxyribonuclease III Proteins 0.000 description 1
- 210000003722 extracellular fluid Anatomy 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 230000005669 field effect Effects 0.000 description 1
- 150000005699 fluoropyrimidines Chemical class 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 108020001507 fusion proteins Proteins 0.000 description 1
- 102000037865 fusion proteins Human genes 0.000 description 1
- 238000012239 gene modification Methods 0.000 description 1
- 230000005017 genetic modification Effects 0.000 description 1
- 235000013617 genetically modified food Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 235000021021 grapes Nutrition 0.000 description 1
- 210000004209 hair Anatomy 0.000 description 1
- 239000003228 hemolysin Substances 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 238000000589 high-performance liquid chromatography-mass spectrometry Methods 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 125000000487 histidyl group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C([H])=N1 0.000 description 1
- 230000006801 homologous recombination Effects 0.000 description 1
- 238000002744 homologous recombination Methods 0.000 description 1
- 230000015784 hyperosmotic salinity response Effects 0.000 description 1
- 238000002847 impedance measurement Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000013383 initial experiment Methods 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 239000011147 inorganic material Substances 0.000 description 1
- 229920000592 inorganic polymer Polymers 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000037427 ion transport Effects 0.000 description 1
- 239000002608 ionic liquid Substances 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 238000011898 label-free detection Methods 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 239000013554 lipid monolayer Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004020 luminiscence type Methods 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 125000003588 lysine group Chemical class [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 230000021121 meiosis Effects 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- SJFKGZZCMREBQH-UHFFFAOYSA-N methyl ethanimidate Chemical compound COC(C)=N SJFKGZZCMREBQH-UHFFFAOYSA-N 0.000 description 1
- 108091070501 miRNA Proteins 0.000 description 1
- 239000002679 microRNA Substances 0.000 description 1
- 238000004377 microelectronic Methods 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 238000002887 multiple sequence alignment Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 230000001293 nucleolytic effect Effects 0.000 description 1
- 108010014203 outer membrane phospholipase A Proteins 0.000 description 1
- 238000010422 painting Methods 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 150000002972 pentoses Chemical class 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 235000012015 potatoes Nutrition 0.000 description 1
- 238000011533 pre-incubation Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 108020001580 protein domains Proteins 0.000 description 1
- 150000003212 purines Chemical class 0.000 description 1
- VTGOHKSTWXHQJK-UHFFFAOYSA-N pyrimidin-2-ol Chemical class OC1=NC=CC=N1 VTGOHKSTWXHQJK-UHFFFAOYSA-N 0.000 description 1
- 150000003230 pyrimidines Chemical class 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 238000007637 random forest analysis Methods 0.000 description 1
- 238000010188 recombinant method Methods 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 238000005932 reductive alkylation reaction Methods 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 239000002336 ribonucleotide Substances 0.000 description 1
- 125000002652 ribonucleotide group Chemical group 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 102220198221 rs1057519921 Human genes 0.000 description 1
- 102220278254 rs1554096653 Human genes 0.000 description 1
- 102220289580 rs33916541 Human genes 0.000 description 1
- 102220036433 rs35389822 Human genes 0.000 description 1
- 102200076325 rs5658 Human genes 0.000 description 1
- 102200026914 rs730882246 Human genes 0.000 description 1
- 102220188881 rs747642461 Human genes 0.000 description 1
- 102220158369 rs886047453 Human genes 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 239000013535 sea water Substances 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- 239000003579 shift reagent Substances 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 239000004945 silicone rubber Substances 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 125000006850 spacer group Chemical group 0.000 description 1
- 230000036262 stenosis Effects 0.000 description 1
- 208000037804 stenosis Diseases 0.000 description 1
- 238000012706 support-vector machine Methods 0.000 description 1
- 238000012353 t test Methods 0.000 description 1
- 210000001138 tear Anatomy 0.000 description 1
- 238000011191 terminal modification Methods 0.000 description 1
- 229940113082 thymine Drugs 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 230000005945 translocation Effects 0.000 description 1
- 239000001226 triphosphate Substances 0.000 description 1
- 235000011178 triphosphate Nutrition 0.000 description 1
- UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 description 1
- 239000000107 tumor biomarker Substances 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 230000005641 tunneling Effects 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 229940035893 uracil Drugs 0.000 description 1
- DRTQHJPVMGBUCF-UHFFFAOYSA-N uracil arabinoside Natural products OC1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-UHFFFAOYSA-N 0.000 description 1
- 229940045145 uridine Drugs 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/48785—Electrical and electronic details of measuring devices for physical analysis of liquid biological material not specific to a particular test method, e.g. user interface or power supply
- G01N33/48792—Data management, e.g. communication with processing unit
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6858—Allele-specific amplification
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y15/00—Nanotechnology for interacting, sensing or actuating, e.g. quantum dots as markers in protein assays or molecular motors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6869—Methods for sequencing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/02—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating impedance
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/48707—Physical analysis of biological material of liquid biological material by electrical means
- G01N33/48721—Investigating individual macromolecules, e.g. by translocation through nanopores
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6875—Nucleoproteins
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
- G16B30/10—Sequence alignment; Homology search
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Analytical Chemistry (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Nanotechnology (AREA)
- General Physics & Mathematics (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Medical Informatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Computational Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Evolutionary Biology (AREA)
- Theoretical Computer Science (AREA)
- Cell Biology (AREA)
- Optics & Photonics (AREA)
- Human Computer Interaction (AREA)
- Databases & Information Systems (AREA)
- Electrochemistry (AREA)
Description
複数の測定の系列から、複数の測定の特性を表す時系列的特徴の特徴ベクトルを導出するステップと、
導出された特徴ベクトルと少なくとも1つの他の特徴ベクトルとの類似性を判定するステップと
を含む、方法を提供する。
電流=和[fn(Bn)]+E
ここで、fnは、測定システムにおける各位置nに存在する各塩基Bnの係数であり、Eは、実験の変動による偶然誤差である。当技術分野で公知の多くの方法のいずれか1つを代わりに用いることができるが、データは、最小二乗法によりこのモデルに適合させる。図4及び5は、電流測定に対する最良モデル適合のプロットである。データがこのモデルにより十分に記述された場合、ポイントは、一般的実験誤差(例えば、2pA)内で対角線を厳密にたどるはずである。これは、いずれの組の係数についてもデータがこの線形モデルによって十分に記述されないことを示す場合ではない。
1.長初期特徴ベクトルを生成させる。我々はこれをランドマークベクトルと呼ぶ。
2.各特徴ベクトルをランドマークベクトルとアライメントする。
3.新たな空のランドマークベクトルを生成させる。
4.ステップ2からのアライメントされた特徴ベクトルに沿って最初から最後まで移動し、アライメントした特徴ベクトルの部分pが範囲r内にある場合には、当位置における平均値をランドマークベクトルに加える。
5.ステップ4で生成したランドマークベクトルが連続反復で同じになるまで、又は反復の最大回数に到達するまで、2〜4を繰り返す。
1.特徴ベクトルを一連のデルタとして表すこと。
2.特徴ベクトルを電流レベルに基づく一連のクラスとして表すこと。
3.特徴ベクトルを一連のマイルストーン(十分に特徴付けられた)特徴として表すこと。
緩衝溶液:1M NaCl、100mMヘペスpH8.0、1mM ATP、1mM MgCl2、1mM DTT、10mMフェロシアン化カリウム(II)、10mMフェロシアン化カリウム(III)、Pt電極
ナノ細孔:MS(B2C)8MspAMS−
(G75S/G77S/L88N/D90N/D91N/D93N/D118R/Q126R/D134R/E139K)8
酵素:ヘリカーゼ100nM
この実施例は、特徴ベクトルのあらかじめ決定したライブラリからの溶液中のDNA分子の同定の方法を述べる。
ライブラリ構築物及び特徴ベクトルを上で示した方法を用いて生成したが、分子13(ANA ID番号13)のライブラリ特徴ベクトルにおいて、配列に施された3つの変化[old][position][new]、T335A、G357T、C385A(ANA ID番号19)が存在した。分子13の例は、ライブラリ分子に対するこれらの位置における変化を有する(すなわち、3SNP)。ライブラリ特徴ベクトルに対するこれらのSNPの影響を図16に示す。
この実施例は、模擬データにより機能する。60の特徴ベクトル(平均電流の)の組をANA ID番号13についてシミュレートする。シミュレーションの10例は、SNPも含む。1pAの標準偏差を有するガウスノイズを各値に加え、各ベクトル内の値の5%をランダムに削除する。データをシミュレートすることのほかに、配列のさらなる知識を用いない。
2つの場合を考慮する。すなわち、第1に2つの種が存在する場合及び第2に3つの種が存在する場合である。データは、実施例2のANA ID番号13、9及び5の配列を用いてシミュレートする。しかし、この実施例については、最初のデータセットのシミュレーション以外は、配列又はモデル情報を用いない。類似性の尺度として対アライメントスコアを用いて、当技術分野で公知である近隣結合により樹を構築する。図23及び24に示すように、これらのデータセットクラスターは、十分にそれぞれ2つの及び3つの集団となった。これらのクラスターを分離するための閾値を定義することができた(直線の長さが類似性を示す)ことも明らかである。
この実施例では、上述の重複配列S1〜S18からの模擬データを用いる。しかし、アセンブリ過程を示すために、我々は、配列がミスマッチ領域なしに重複するように(図12にされたように)すべての配列に共通の開始及び終了における配列を除去する(実施例2で述べたように)。配列が重複することが保証されているので、比較的単純な方法を用いることができる。これが当てはまらない場合、上述のような当技術分野で公知のものから適応させたより複雑なアセンブリアルゴリズムを用いることができる。
Claims (28)
- ナノ細孔を経るポリマーの輸送中に行われる前記ポリマーの複数の測定の時間的な順序の系列を解析する方法であって、前記ナノ細孔が膜貫通タンパク質細孔であるか、または前記ナノ細孔が絶縁材料の固体層における開口部であり、前記複数の測定が前記ナノ細孔中のkマー(k-mer)のアイデンティティに依存し、kマーが前記ポリマーのk個のポリマー単位であり、kが正の整数であり、前記時間的な順序の系列における連続的測定の群が、各群について異なる各kマーに依存し、
前記方法が、
前記複数の測定の前記系列から、前記連続的測定の群を識別することにより、前記複数の測定の特性を表す時系列的な特徴の特徴ベクトルを導出するステップであって、各群について、1つ又は複数の前記特徴の値を導出し、前記特徴が
前記複数の測定の群の平均、
前記複数の測定の群の期間、
前記複数の測定の群の分散、
非対称情報、
前記複数の測定の信頼情報、
前記複数の測定の群の分布、又は
それらのいずれかの組合せ、
を含む、特徴ベクトルを導出するステップと、
前記導出された特徴ベクトルと、対照ポリマーの、少なくとも1つの他の特徴ベクトルとの類似性を判定するステップと
を含む方法。 - 前記少なくとも1つの他の特徴ベクトルが、少なくとも1つのクラスについて記憶装置に保存された少なくとも1つの他の特徴ベクトルである、請求項1に記載の方法。
- 前記記憶装置に保存された前記少なくとも1つの他の特徴ベクトルが、測定される前記ポリマーに応じて選択される、請求項2に記載の方法。
- 前記記憶装置に保存された前記少なくとも1つの他の特徴ベクトルが、断片の前記特徴ベクトルから構成された共通ポリマーの全特徴ベクトルを含む、請求項2又は3に記載の方法。
- 類似性を判定する前記ステップが、前記導出された特徴ベクトルの全体又は一部と前記記憶装置に保存された前記少なくとも1つの他の特徴ベクトルの全体との間の類似性を判定するステップを含む、請求項2〜4のいずれか一項に記載の方法。
- 類似性を判定する前記ステップが、前記導出された特徴ベクトルの全体又は一部と前記記憶装置に保存された前記少なくとも1つの他の特徴ベクトルの一部との間の類似性を判定するステップを含む、請求項2〜4のいずれか一項に記載の方法。
- 前記導出された特徴ベクトルが導出される前記ポリマーを、前記判定された類似性に基づいて前記クラスに属するものとして分類するステップをさらに含む、請求項2〜6のいずれか一項に記載の方法。
- 前記少なくとも1つの他の特徴ベクトルが、同じ方法を用いて導出された特徴ベクトルである、請求項1に記載の方法。
- 前記少なくとも1つの他の特徴ベクトルが、同じ方法を用いて導出された複数の特徴ベクトルであり、前記方法が、該特徴ベクトルの重複部分の類似性に基づいて共通ポリマーの断片であるポリマーから導出される特徴ベクトルを同定するステップをさらに含む、請求項8に記載の方法。
- 前記同定された断片の前記特徴ベクトルから前記共通ポリマーの全特徴ベクトルを構築するステップをさらに含む、請求項8に記載の方法。
- 前記少なくとも1つの他の特徴ベクトルが、同じ方法を用いて導出された複数の特徴ベクトルであり、前記方法が、類似の特徴ベクトルのクラスターをクラスとして同定するステップと、該特徴ベクトルが導出される前記ポリマーを同定されたクラスに属するものとして分類するステップとをさらに含む、請求項8に記載の方法。
- 異なるクラスに属する特徴ベクトルの数を数えるステップをさらに含む、請求項7又は11に記載の方法。
- 前記導出された特徴ベクトルが、前記ポリマーが属すると分類されるクラスについて特徴ベクトルと異なる局所領域を同定するステップをさらに含む、請求項7、11又は12に記載の方法。
- 前記少なくとも1つの他の特徴ベクトルが、記憶装置に保存された特徴ベクトルを含み、類似性を判定する前記ステップが、前記導出された特徴ベクトルが該記憶装置に保存された前記少なくとも1つの他の特徴ベクトルと異なる局所領域を決定するステップを含む、請求項1に記載の方法。
- 前記複数の測定が電気測定である、請求項1〜14のいずれか一項に記載の方法。
- 前記複数の測定がナノ細孔を通るイオン電流の測定を含む、請求項1〜15のいずれか一項に記載の方法。
- 前記複数の測定が、イオン電流のほかの少なくも1つの追加の特性の測定をさらに含む、請求項16に記載の方法。
- 少なくも1つの追加の特性の前記測定がFET測定、光学的測定又は両方を含む、請求項17に記載の方法。
- 前記ポリマーがポリヌクレオチドであり、前記ポリマー単位がヌクレオチドである、請求項1〜18のいずれか一項に記載の方法。
- 前記ナノ細孔が生体細孔である、請求項1〜19のいずれか一項に記載の方法。
- 前記ナノ細孔を経る前記ポリマーの前記輸送が、連続するkマーが前記ナノ細孔において歯止めで動かされるような状態で行われる、請求項1〜20のいずれか一項に記載の方法。
- 前記ポリマーの前記輸送が、ポリマー結合タンパク質である分子歯止めにより制御される、請求項1〜21のいずれか一項に記載の方法。
- 前記類似性を判定するステップは、対での類似性のアライメントベース又はサブベクトルベースの測定を用いて実行される、請求項1〜22のいずれか一項に記載の方法。
- 前記類似性を判定するステップは、前記少なくとも1つの他の特徴ベクトルの隠れマルコフモデル(Hidden Markov Model)を用いて、前記導出された特徴ベクトルをアライメントすることを含む、請求項1〜22のいずれか一項に記載の方法。
- ナノ細孔を経て前記ポリマーを輸送するステップと、
前記ポリマーの連続する系列の測定を行うステップと
をさらに含む、請求項1〜24のいずれか一項に記載の方法。 - 標的ポリマーの存在、非存在又は量を推定する方法であって、
ナノ細孔を経てポリマーを輸送するステップと、
該ポリマーの連続する系列の測定を行うステップと、
請求項1から24までのいずれか一項に記載の方法を用いて測定の系列を解析するステップと、
該解析に基づいて標的ポリマーの存在、非存在又は量を推定するステップと
を含む、方法。 - コンピュータ装置により実行することができ、請求項1〜24のいずれか一項に記載の方法を実施するための実行に基づいて構成されたコンピュータプログラム。
- 請求項1〜24のいずれか一項に記載の方法を実施するように構成された解析装置。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261599573P | 2012-02-16 | 2012-02-16 | |
US61/599,573 | 2012-02-16 | ||
PCT/GB2013/050381 WO2013121224A1 (en) | 2012-02-16 | 2013-02-18 | Analysis of measurements of a polymer |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2015509710A JP2015509710A (ja) | 2015-04-02 |
JP2015509710A5 JP2015509710A5 (ja) | 2017-08-31 |
JP6226888B2 true JP6226888B2 (ja) | 2017-11-08 |
Family
ID=47749886
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2014557122A Active JP6226888B2 (ja) | 2012-02-16 | 2013-02-18 | ポリマーの測定の解析 |
Country Status (10)
Country | Link |
---|---|
US (3) | US20150057948A1 (ja) |
EP (2) | EP2814980B8 (ja) |
JP (1) | JP6226888B2 (ja) |
KR (1) | KR102106499B1 (ja) |
CN (1) | CN104321441B (ja) |
AU (1) | AU2013220179B2 (ja) |
BR (1) | BR112014020211A2 (ja) |
CA (1) | CA2866587C (ja) |
IN (1) | IN2014DN06795A (ja) |
WO (1) | WO2013121224A1 (ja) |
Families Citing this family (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0724736D0 (en) | 2007-12-19 | 2008-01-30 | Oxford Nanolabs Ltd | Formation of layers of amphiphilic molecules |
US8285719B1 (en) | 2008-08-08 | 2012-10-09 | The Research Foundation Of State University Of New York | System and method for probabilistic relational clustering |
EP2758545B1 (en) * | 2011-09-23 | 2017-07-26 | Oxford Nanopore Technologies Limited | Analysis of a polymer comprising polymer units |
GB201202519D0 (en) | 2012-02-13 | 2012-03-28 | Oxford Nanopore Tech Ltd | Apparatus for supporting an array of layers of amphiphilic molecules and method of forming an array of layers of amphiphilic molecules |
JP6226888B2 (ja) | 2012-02-16 | 2017-11-08 | オックスフォード ナノポール テクノロジーズ リミテッド | ポリマーの測定の解析 |
GB201313121D0 (en) | 2013-07-23 | 2013-09-04 | Oxford Nanopore Tech Ltd | Array of volumes of polar medium |
GB201222928D0 (en) | 2012-12-19 | 2013-01-30 | Oxford Nanopore Tech Ltd | Analysis of a polynucleotide |
KR102551897B1 (ko) * | 2014-10-16 | 2023-07-06 | 옥스포드 나노포어 테크놀로지즈 피엘씨 | 폴리머의 분석 |
GB201418512D0 (en) | 2014-10-17 | 2014-12-03 | Oxford Nanopore Tech Ltd | Electrical device with detachable components |
US10302972B2 (en) | 2015-01-23 | 2019-05-28 | Pacific Biosciences Of California, Inc. | Waveguide transmission |
EP4293349A3 (en) | 2015-02-05 | 2024-02-21 | President and Fellows of Harvard College | Nanopore sensor including fluidic passage |
GB201508669D0 (en) | 2015-05-20 | 2015-07-01 | Oxford Nanopore Tech Ltd | Methods and apparatus for forming apertures in a solid state membrane using dielectric breakdown |
EP3332032B1 (en) | 2015-08-06 | 2023-12-27 | Pacific Biosciences Of California, Inc. | Integrated circuits for selectively addressing sparsely arranged electronic measurement devices |
US10783268B2 (en) | 2015-11-10 | 2020-09-22 | Hewlett Packard Enterprise Development Lp | Data allocation based on secure information retrieval |
WO2017149317A1 (en) | 2016-03-02 | 2017-09-08 | Oxford Nanopore Technologies Limited | Mutant pore |
US11514289B1 (en) * | 2016-03-09 | 2022-11-29 | Freenome Holdings, Inc. | Generating machine learning models using genetic data |
US10823721B2 (en) | 2016-07-05 | 2020-11-03 | Quantapore, Inc. | Optically based nanopore sequencing |
SG11201811556RA (en) * | 2016-07-06 | 2019-01-30 | Guardant Health Inc | Methods for fragmentome profiling of cell-free nucleic acids |
GB201611770D0 (en) | 2016-07-06 | 2016-08-17 | Oxford Nanopore Tech | Microfluidic device |
WO2018034745A1 (en) * | 2016-08-18 | 2018-02-22 | The Regents Of The University Of California | Nanopore sequencing base calling |
US11080301B2 (en) | 2016-09-28 | 2021-08-03 | Hewlett Packard Enterprise Development Lp | Storage allocation based on secure data comparisons via multiple intermediaries |
GB201619930D0 (en) | 2016-11-24 | 2017-01-11 | Oxford Nanopore Tech | Apparatus and methods for controlling insertion of a membrane channel into a membrane |
US20200251184A1 (en) * | 2016-12-16 | 2020-08-06 | Osaka University | Classification analysis method, classification analysis device, and storage medium for classification analysis |
GB201707122D0 (en) | 2017-05-04 | 2017-06-21 | Oxford Nanopore Tech Ltd | Pore |
GB201707138D0 (en) * | 2017-05-04 | 2017-06-21 | Oxford Nanopore Tech Ltd | Machine learning analysis of nanopore measurements |
NZ759548A (en) * | 2017-09-15 | 2024-05-31 | Illumina Inc | Sequence-detection system |
GB2569630B (en) | 2017-12-21 | 2022-10-12 | Sharp Life Science Eu Ltd | Droplet Interfaces in Electro-wetting Devices |
GB2589159B (en) | 2017-12-29 | 2023-04-05 | Clear Labs Inc | Nucleic acid sequencing apparatus |
EP3745857A1 (de) | 2018-02-02 | 2020-12-09 | Bayer Aktiengesellschaft | Bekämpfung resistenter schadorganismen |
US20210079461A1 (en) * | 2018-04-20 | 2021-03-18 | The Regents Of The University Of California | Nucleic Acid Sequencing Methods and Computer-Readable Media for Practicing Same |
CN112203767B (zh) | 2018-05-24 | 2023-04-11 | 牛津纳米孔科技公司 | 电润湿装置中的液滴界面 |
GB201814369D0 (en) | 2018-09-04 | 2018-10-17 | Oxford Nanopore Tech Ltd | Method for determining a polymersequence |
GB201819378D0 (en) * | 2018-11-28 | 2019-01-09 | Oxford Nanopore Tech Ltd | Analysis of nanopore signal using a machine-learning technique |
WO2020109800A1 (en) | 2018-11-28 | 2020-06-04 | Oxford Nanopore Technologies Ltd. | Sensing system and method of operation |
WO2020183172A1 (en) | 2019-03-12 | 2020-09-17 | Oxford Nanopore Technologies Inc. | Nanopore sensing device and methods of operation and of forming it |
US20220254446A1 (en) * | 2019-05-22 | 2022-08-11 | Icahn School Of Medicine At Mount Sinai | Method for de novo detection, identification and fine mapping of multiple forms of nucleic acid modifications |
CN110628597B (zh) * | 2019-10-19 | 2023-04-25 | 上海新微技术研发中心有限公司 | 拉曼光谱法生物分子测序方法 |
US11651281B2 (en) * | 2020-05-18 | 2023-05-16 | International Business Machines Corporation | Feature catalog enhancement through automated feature correlation |
CN113030548A (zh) * | 2021-03-09 | 2021-06-25 | 南京邮电大学 | 基于局域阈值的纳米孔检测电流信号特征信息提取方法及装置 |
GB202103605D0 (en) | 2021-03-16 | 2021-04-28 | Oxford Nanopore Tech Ltd | Alignment of target and reference sequences of polymer units |
EP4341433A1 (en) | 2021-05-19 | 2024-03-27 | Oxford Nanopore Technologies PLC | Methods for complement strand sequencing |
WO2023029044A1 (zh) * | 2021-09-06 | 2023-03-09 | 百图生科(北京)智能技术有限公司 | 用于单细胞测序的方法、装置、设备、介质和程序产品 |
CN113837036B (zh) * | 2021-09-09 | 2024-08-02 | 成都齐碳科技有限公司 | 生物聚合物的表征方法、装置、设备及计算机存储介质 |
CN114908358B8 (zh) * | 2022-04-14 | 2024-06-21 | 孔确(成都)科技有限公司 | 一种两亲性分子层的制备方法及装置 |
GB202215442D0 (en) | 2022-10-19 | 2022-11-30 | Oxford Nanopore Tech Plc | Analysis of a polymer |
WO2024099985A1 (en) | 2022-11-10 | 2024-05-16 | Bayer Aktiengesellschaft | Targeted crop protection product application based on genetic profiles |
GB202216905D0 (en) | 2022-11-11 | 2022-12-28 | Oxford Nanopore Tech Plc | Novel pore monomers and pores |
JP2024131014A (ja) * | 2023-03-15 | 2024-09-30 | Dic株式会社 | 樹脂物性値予測装置及び樹脂物性値の予測方法 |
Family Cites Families (78)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5795782A (en) | 1995-03-17 | 1998-08-18 | President & Fellows Of Harvard College | Characterization of individual polymer molecules based on monomer-interface interactions |
US6128587A (en) * | 1997-01-14 | 2000-10-03 | The Regents Of The University Of California | Method and apparatus using Bayesian subfamily identification for sequence analysis |
JPH11178575A (ja) * | 1997-12-22 | 1999-07-06 | Hitachi Ltd | Dna塩基配列解析装置、方法及び記録媒体 |
US6267872B1 (en) | 1998-11-06 | 2001-07-31 | The Regents Of The University Of California | Miniature support for thin films containing single channels or nanopores and methods for using same |
WO2000039333A1 (en) | 1998-12-23 | 2000-07-06 | Jones Elizabeth Louise | Sequencing method using magnifying tags |
US6627067B1 (en) | 1999-06-22 | 2003-09-30 | President And Fellows Of Harvard College | Molecular and atomic scale evaluation of biopolymers |
AU2002239284A1 (en) | 2000-11-27 | 2002-06-03 | The Regents Of The University Of California | Methods and devices for characterizing duplex nucleic acid molecules |
US20020197618A1 (en) | 2001-01-20 | 2002-12-26 | Sampson Jeffrey R. | Synthesis and amplification of unstructured nucleic acids for rapid sequencing |
JP2002325581A (ja) * | 2001-04-27 | 2002-11-12 | Adgene Co Ltd | 核酸溶解曲線及び核酸解離曲線を用いた未知あるいは既知核酸変異検出法及び表示法 |
JP2003256435A (ja) | 2002-03-06 | 2003-09-12 | Fujitsu Ltd | 配列データ統合処理方法、配列データ統合処理装置及び配列データ統合処理プログラム |
US7220405B2 (en) | 2003-09-08 | 2007-05-22 | E. I. Du Pont De Nemours And Company | Peptide-based conditioners and colorants for hair, skin, and nails |
US20050136408A1 (en) | 2003-12-19 | 2005-06-23 | May Tom-Moy | Methods and systems for characterizing a polymer |
JP2005176730A (ja) | 2003-12-19 | 2005-07-07 | Hitachi Ltd | cDNA配列をゲノム配列にマッピングする方法 |
US7279337B2 (en) | 2004-03-10 | 2007-10-09 | Agilent Technologies, Inc. | Method and apparatus for sequencing polymers through tunneling conductance variation detection |
WO2006028508A2 (en) * | 2004-03-23 | 2006-03-16 | President And Fellows Of Harvard College | Methods and apparatus for characterizing polynucleotides |
KR100614827B1 (ko) | 2004-05-06 | 2006-08-25 | 재단법인서울대학교산학협력재단 | 양방향 은닉 마코프 모델을 이용한 완숙한마이크로알엔에이 위치예측방법 및 이를 구현하기 위한컴퓨터 프로그램을 기록한 저장매체 |
WO2005124888A1 (en) | 2004-06-08 | 2005-12-29 | President And Fellows Of Harvard College | Suspended carbon nanotube field effect transistor |
US20060019259A1 (en) | 2004-07-22 | 2006-01-26 | Joyce Timothy H | Characterization of biopolymers by resonance tunneling and fluorescence quenching |
US20130071837A1 (en) | 2004-10-06 | 2013-03-21 | Stephen N. Winters-Hilt | Method and System for Characterizing or Identifying Molecules and Molecular Mixtures |
US20060086626A1 (en) | 2004-10-22 | 2006-04-27 | Joyce Timothy H | Nanostructure resonant tunneling with a gate voltage source |
GB0505971D0 (en) | 2005-03-23 | 2005-04-27 | Isis Innovation | Delivery of molecules to a lipid bilayer |
WO2007065025A2 (en) | 2005-11-29 | 2007-06-07 | Wisconsin Alumni Research Foundation | Method of dna analysis using micro/nanochannel |
US20100291548A1 (en) | 2006-03-12 | 2010-11-18 | Applera Corporation | Methods of Detecting Target Nucleic Acids |
US8116988B2 (en) | 2006-05-19 | 2012-02-14 | The University Of Chicago | Method for indexing nucleic acid sequences for computer based searching |
US7731826B2 (en) | 2006-08-17 | 2010-06-08 | Electronic Bio Sciences, Llc | Controlled translocation of a polymer in an electrolytic sensing system |
US8003319B2 (en) | 2007-02-02 | 2011-08-23 | International Business Machines Corporation | Systems and methods for controlling position of charged polymer inside nanopore |
US20110121840A1 (en) | 2007-02-20 | 2011-05-26 | Gurdial Singh Sanghera | Lipid Bilayer Sensor System |
CA2684801C (en) | 2007-04-04 | 2017-10-10 | The Regents Of The University Of California | Compositions, devices, systems, and methods for using a nanopore |
EP2195648B1 (en) | 2007-09-12 | 2019-05-08 | President and Fellows of Harvard College | High-resolution molecular graphene sensor comprising an aperture in the graphene layer |
GB2453377A (en) * | 2007-10-05 | 2009-04-08 | Isis Innovation | Transmembrane protein pores and molecular adapters therefore. |
GB0724736D0 (en) | 2007-12-19 | 2008-01-30 | Oxford Nanolabs Ltd | Formation of layers of amphiphilic molecules |
US8628940B2 (en) | 2008-09-24 | 2014-01-14 | Pacific Biosciences Of California, Inc. | Intermittent detection during analytical reactions |
CN102245760A (zh) | 2008-07-07 | 2011-11-16 | 牛津纳米孔技术有限公司 | 酶-孔构建体 |
CA2730068A1 (en) | 2008-07-07 | 2010-01-14 | Oxford Nanopore Technologies Limited | Base-detecting pore |
CA2774710C (en) | 2008-09-22 | 2016-08-02 | University Of Washington | Msp nanopores and related methods |
WO2010053820A1 (en) | 2008-10-29 | 2010-05-14 | Trustees Of Boston University | Sequence preserved dna conversion |
US8452546B1 (en) | 2008-11-07 | 2013-05-28 | Electronic Biosciences, Inc. | Method for deducing a polymer sequence from a nominal base-by-base measurement |
GB0820927D0 (en) * | 2008-11-14 | 2008-12-24 | Isis Innovation | Method |
CN102482330A (zh) | 2009-01-30 | 2012-05-30 | 牛津纳米孔技术有限公司 | 酶突变体 |
CA2750879C (en) | 2009-01-30 | 2018-05-22 | Oxford Nanopore Technologies Limited | Adaptors for nucleic acid constructs in transmembrane sequencing |
GB0905140D0 (en) | 2009-03-25 | 2009-05-06 | Isis Innovation | Method |
WO2010117470A2 (en) * | 2009-04-10 | 2010-10-14 | Pacific Biosciences Of California, Inc. | Nanopore sequencing devices and methods |
AU2010240670B2 (en) | 2009-04-20 | 2015-08-20 | Oxford Nanopore Technologies Limited | Lipid bilayer sensor array |
CA2772789C (en) | 2009-09-18 | 2018-10-30 | President And Fellows Of Harvard College | Bare single-layer graphene membrane having a nanopore enabling high-sensitivity molecular detection and analysis |
US9127313B2 (en) | 2009-12-01 | 2015-09-08 | Oxford Nanopore Technologies Limited | Biochemical analysis instrument |
US8748091B2 (en) | 2009-12-18 | 2014-06-10 | The Board Of Trustees Of The University Of Illinois | Characterizing stretched polynucleotides in a synthetic nanopassage |
US8324914B2 (en) | 2010-02-08 | 2012-12-04 | Genia Technologies, Inc. | Systems and methods for characterizing a molecule |
EP3933402A1 (en) | 2010-02-23 | 2022-01-05 | University of Washington | Method of making unsupported artificial mycolic acid membranes |
EP2580588B1 (en) | 2010-06-08 | 2014-09-24 | President and Fellows of Harvard College | Nanopore device with graphene supported artificial lipid membrane |
US20140051068A1 (en) | 2010-09-07 | 2014-02-20 | The Regents Of The University Of California | Control of dna movement in a nanopore at one nucleotide precision by a processive enzyme |
US9068221B2 (en) | 2011-02-09 | 2015-06-30 | Life Technologies Corporation | Method of analysis of genetic markers |
KR101939420B1 (ko) | 2011-02-11 | 2019-01-16 | 옥스포드 나노포어 테크놀로지즈 리미티드 | 돌연변이체 세공 |
WO2012135658A2 (en) | 2011-03-30 | 2012-10-04 | Noblegen Biosciences, Inc. | Sequence preserved dna conversion for optical nanopore sequencing |
WO2012138357A1 (en) | 2011-04-04 | 2012-10-11 | President And Fellows Of Harvard College | Nanopore sensing by local electrical potential measurement |
SG10201604316WA (en) | 2011-05-27 | 2016-07-28 | Oxford Nanopore Tech Ltd | Coupling method |
US9145623B2 (en) | 2011-07-20 | 2015-09-29 | Thermo Fisher Scientific Oy | Transposon nucleic acids comprising a calibration sequence for DNA sequencing |
KR20140050067A (ko) | 2011-07-25 | 2014-04-28 | 옥스포드 나노포어 테크놀로지즈 리미티드 | 막횡단 포어를 사용한 이중 가닥 폴리뉴클레오티드 서열분석을 위한 헤어핀 루프 방법 |
EP2758545B1 (en) | 2011-09-23 | 2017-07-26 | Oxford Nanopore Technologies Limited | Analysis of a polymer comprising polymer units |
KR20140090633A (ko) | 2011-10-21 | 2014-07-17 | 옥스포드 나노포어 테크놀로지즈 리미티드 | 포어 및 hel308 헬리카제를 사용하여 표적 폴리뉴클레오티드를 특성화하는 방법 |
US9617591B2 (en) | 2011-12-29 | 2017-04-11 | Oxford Nanopore Technologies Ltd. | Method for characterising a polynucleotide by using a XPD helicase |
AU2012360244B2 (en) | 2011-12-29 | 2018-08-23 | Oxford Nanopore Technologies Limited | Enzyme method |
EP2807476A4 (en) | 2012-01-20 | 2015-12-09 | Genia Technologies Inc | MOLECULAR DETECTION AND SEQUENCING USING NANOPORES |
JP6312607B2 (ja) | 2012-02-16 | 2018-04-18 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | 酵素仲介タンパク質トランスロケーションのためのナノポアセンサー |
JP6226888B2 (ja) | 2012-02-16 | 2017-11-08 | オックスフォード ナノポール テクノロジーズ リミテッド | ポリマーの測定の解析 |
JP6271505B2 (ja) | 2012-04-10 | 2018-01-31 | オックスフォード ナノポール テクノロジーズ リミテッド | 変異体ライセニンポア |
US10612083B2 (en) | 2012-04-19 | 2020-04-07 | University Of Washington Through Its Center For Commercialization | Methods and compositions for generating reference maps for nanopore-based polymer analysis |
US9116118B2 (en) | 2012-06-08 | 2015-08-25 | Pacific Biosciences Of California, Inc. | Modified base detection with nanopore sequencing |
WO2014013260A1 (en) | 2012-07-19 | 2014-01-23 | Oxford Nanopore Technologies Limited | Modified helicases |
AU2013291765C1 (en) | 2012-07-19 | 2019-08-08 | Oxford Nanopore Technologies Limited | Enzyme construct |
WO2014013259A1 (en) | 2012-07-19 | 2014-01-23 | Oxford Nanopore Technologies Limited | Ssb method |
GB201313121D0 (en) | 2013-07-23 | 2013-09-04 | Oxford Nanopore Tech Ltd | Array of volumes of polar medium |
JP6375301B2 (ja) | 2012-10-26 | 2018-08-15 | オックスフォード ナノポール テクノロジーズ リミテッド | 液滴界面 |
GB201222928D0 (en) | 2012-12-19 | 2013-01-30 | Oxford Nanopore Tech Ltd | Analysis of a polynucleotide |
LT3074534T (lt) | 2013-11-26 | 2019-08-26 | Illumina, Inc. | Būdai, skirti polinukleotido sekoskaitai |
WO2015140535A1 (en) | 2014-03-21 | 2015-09-24 | Oxford Nanopore Technologies Limited | Analysis of a polymer from multi-dimensional measurements |
GB201408652D0 (en) | 2014-05-15 | 2014-07-02 | Oxford Nanopore Tech Ltd | Model adjustment during analysis of a polymer from nanopore measurements |
US9925679B2 (en) | 2014-05-19 | 2018-03-27 | I+D+M Creative, Llc | Devices and methods for assisting with slicing items |
KR102551897B1 (ko) | 2014-10-16 | 2023-07-06 | 옥스포드 나노포어 테크놀로지즈 피엘씨 | 폴리머의 분석 |
-
2013
- 2013-02-18 JP JP2014557122A patent/JP6226888B2/ja active Active
- 2013-02-18 IN IN6795DEN2014 patent/IN2014DN06795A/en unknown
- 2013-02-18 CA CA2866587A patent/CA2866587C/en active Active
- 2013-02-18 EP EP13706058.8A patent/EP2814980B8/en active Active
- 2013-02-18 EP EP20168745.6A patent/EP3736339B1/en active Active
- 2013-02-18 AU AU2013220179A patent/AU2013220179B2/en active Active
- 2013-02-18 KR KR1020147025898A patent/KR102106499B1/ko active IP Right Grant
- 2013-02-18 US US14/379,242 patent/US20150057948A1/en not_active Abandoned
- 2013-02-18 BR BR112014020211A patent/BR112014020211A2/pt not_active Application Discontinuation
- 2013-02-18 CN CN201380020403.6A patent/CN104321441B/zh active Active
- 2013-02-18 WO PCT/GB2013/050381 patent/WO2013121224A1/en active Application Filing
-
2019
- 2019-01-11 US US16/245,306 patent/US11959906B2/en active Active
-
2024
- 2024-02-29 US US18/591,644 patent/US20240264143A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
EP2814980B1 (en) | 2020-04-15 |
IN2014DN06795A (ja) | 2015-05-22 |
KR102106499B1 (ko) | 2020-05-04 |
US20190154655A1 (en) | 2019-05-23 |
CA2866587A1 (en) | 2013-08-22 |
CA2866587C (en) | 2022-07-26 |
WO2013121224A1 (en) | 2013-08-22 |
US11959906B2 (en) | 2024-04-16 |
US20240264143A1 (en) | 2024-08-08 |
EP2814980B8 (en) | 2020-06-10 |
AU2013220179B2 (en) | 2018-11-08 |
EP3736339A1 (en) | 2020-11-11 |
EP3736339B1 (en) | 2022-07-27 |
BR112014020211A2 (pt) | 2017-07-04 |
JP2015509710A (ja) | 2015-04-02 |
AU2013220179A1 (en) | 2014-09-04 |
EP2814980A1 (en) | 2014-12-24 |
CN104321441A (zh) | 2015-01-28 |
US20150057948A1 (en) | 2015-02-26 |
KR20140125874A (ko) | 2014-10-29 |
CN104321441B (zh) | 2016-10-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20240264143A1 (en) | Analysis of measurements of a polymer | |
KR102551897B1 (ko) | 폴리머의 분석 | |
US11085077B2 (en) | Analysis of a polynucleotide via a nanopore system | |
Deamer et al. | Three decades of nanopore sequencing | |
JP5328362B2 (ja) | 細孔を使用する方法 | |
US20230039783A1 (en) | Protein and Peptide Fingerprinting and Sequencing by Nanopore Translocation of Peptide-Oligonucleotide Complexes | |
CN118120017A (zh) | 纳米孔测量信号分析 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20160212 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20160212 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20170124 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20170421 |
|
RD03 | Notification of appointment of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7423 Effective date: 20170713 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20170724 |
|
A524 | Written submission of copy of amendment under article 19 pct |
Free format text: JAPANESE INTERMEDIATE CODE: A524 Effective date: 20170724 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20170912 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20171010 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6226888 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |